*Shinobu Hirai¹, Shoko Tamura¹, Hiroko Shimbo¹ (1. Tokyo Metropolitan Institute of Medical Science)

*Hideo Hagihara¹, Tsuyoshi Miyakawa¹ (1. Div Syst Med Sci, Ctr Med Sci, Fujita Hlth Univ)

*Manabu Takano¹, Tsuyoshi Okada¹, Katsutoshi Shioda¹, Shiro Suda¹ (1. Jichi Medical University Department of Psychiatry)

*Yusuke Murata¹, Keishi Takamure¹, Masayoshi Mori¹, Kenji Ohe¹, Yuji Matsumoto², Yoshifumi Inoue², Munechika Enjoji¹ (1. Dpt Pharmacotherapeutics, Fac Pharmaceut Sci, Fukuoka Univ, 2. Medical Science, Sumitomo Pharma Co., Ltd. )

*Wenbing CHEN CHEN¹, Takashi Asano¹, Naotaka Izuo¹, Jun Yokose¹, Shin-ichi Muramatsu^2,3, Atsumi Nitta¹ (1. Toyama University, 2. Jichi Medical University, 3. Tokyo University)

*Akira Nakajima^1,2, Ayako Watanabe^1,2, Minori Shimada¹, Hayato Maeda^1,2, Tsuyoshi Narumi³, Junji Ichita³, Koh Itoku³ (1. Faculty of Agriculture and Life Science, Hirosaki University, 2. Hirosaki University Graduate School of Sustainable Community Studies, 3. Nihon Haruma Co., Ltd.)

*Akihiro Nakajima¹, Takeshi Kiyoi¹, Li Liu¹, Qiang He¹, Shijie Zheng¹, Hitomi Nakazawa¹, Junsuke Uwada¹, Takayoshi Masuoka¹ (1. Department of Pharmacology, School of Medicine, Kanazawa Medical University )

*Yusuke Nasu¹, Sari Kishikawa¹, Miho Terunuma¹ (1. Div. of Oral Biochemistry, Fac. of Dent. & Grad. Sch. of Med. and Dent. Sci., Niigata Univ)

*Mao Suzuki^1,2, Nobuhiro Nakai¹, Noriko Osumi², Toru Takumi¹ (1. Kobe University School of Medicine , 2. Tohoku University Graduate School of Medicine )

*Kazuna Morikawa¹, Mizuki Uchida¹, Honami Tanaka¹, Akira Yoshimi¹, Yukihiro Noda¹ (1. Div Clin Sci Neuropsychopharmacol, Meijo Univ Fac Pharm)

*Yukio Ago^1,2, Kaiga Katahira³, Lu Chen³, Tatsunori Miyaoka³, Kohei Kitagawa⁴, Rei Yokoyama^1,4, Shuto Takeuchi⁴, Mei Yamada³, Zihao Jin³, Kenji Ishimoto³, Tomohito Tsukamoto³, Nobumasa Hino^3,5, Takanobu Nakazawa⁶, Hitoshi Hashimoto^4,7,8,9,10, Shinsaku Nakagawa^2,3 (1. Dept Cell Mol Pharmacol, Grad Sch Biomed Health Sci, Hiroshima Univ, 2. MEI Center, Osaka Univ, 3. Lab Biopharmaceut, Grad Sch Pharmaceut Sci, Osaka Univ, 4. Lab Mol Neuropharmacol, Grad Sch Pharmaceut Sci, Osaka Univ, 5. CiDER, Osaka Univ, 6. Dept Biosci, Grad Sch Life Sci, Tokyo Univ Agric, 7. United Grad Sch Child Dev, Osaka Univ, 8. Inst Datability Sci, Osaka Univ, 9. Inst Open Transdiscip Res Initiatives, Osaka Univ, 10. Dept Mol Pharmaceut Sci, Grad Sch Med, Osaka Univ)

*Natsuko Hitora-Imamura^1,2, Yuki Honshuku^1,2, Yurika Miyagami², Hiroshi Nomura^3,2, Yuki Kurauchi¹, Hiroshi Katsuki¹, Masabumi Minami² (1. Dept Chemico-Pharmacol Sci, Faculty of Life Sciences, Kumamoto University, 2. Dept Pharmacol, Grad Sch Pharm Sci, Hokkaido Univ, 3. Dept Cognitive Funct & Pathol, Grad Sch Med Sci, Nagoya City Univ., Nagoya, Japan)

*Hinano Yonemaru^1,2, Takaaki Ozawa¹, Takatoshi Hikida¹ (1. Institute for Protein Research, Osaka University, 2. Graduate School of Frontier Biosciences, Osaka University)

*Seiryu Suzuki¹, Yuichiro Sugimori¹, Takashi Asano¹, Naotaka Izuo¹, Jun Yokose¹, Shin-Ichi Muramatsu^2,3, Atsumi Nitta¹ (1. Department of Pharmaceutical Therapy & Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Japan, 2. Divison of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan, 3. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

*Yuki Arakida¹, Takashi Asano¹, Kazuki Tokoro¹, Tomoya Horita¹, Naotaka Izuo¹, Jun Yokose¹, Shin-Ichi Muramatsu^2,3, Atsumi Nitta¹ (1. Department of Pharmaceutical Therapy & Neuropharmacology, Faculty of Pharmaceutical Sciences, University of Toyama, Japan, 2. Divison of Neurological Gene Therapy, Open Innovation Center, Jichi Medical University, Shimotsuke, Japan, 3. Center for Gene and Cell Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan)

*Fumiyoshi Morikawa¹, Sayuri Matuzaki¹, Mayumi Munekata¹, Megumi Ootawa¹, Kana Asada¹, Musashi Tachibana¹, Takeshi Hasukawa¹, Toshiya Maruyama¹, Takafumi Tezuka¹, Tomonori Murayama¹, Yuuta Sekinou¹, Kazuki Tabata¹, Sachiko Sirakawa¹, Mitutaka Inomata¹, Juichirou Naoe¹ (1. Asahikawa Keisenkai hospital)

*Fumihiro Tomoda¹, Atsumi Nitta², Tsutomu Tsutomu ³, Hiroko Sugimori³, Hiroko Kurosaki ³ (1. The Faculty of Health Science, Fukui Health Science University, 2. The Department of Pharmaceutical Therapy & Neuropharmacology, University of Toyama , 3. The Second Department of Internal Medicine, University of Toyama)

Ken Inada¹, Yoshitaka Saito¹, Kenji Baba², Daisuke Fukui³, Yuriko Masuda⁴, Sachie Inoue⁴, *Takahiro Masuda² (1. Department of Psychiatry, Kitasato University School of Medicine, 2. Medical Science, Sumitomo Pharma Co., Ltd., 3. Global Data Design Office, Sumitomo Pharma Co., 4. CRECON Medical Assessment Inc)

Takahiro Nemoto^1,2, Miyuki Okumura³, Fumiya Sano³, *Hidenori Maruyama³ (1. Department of Neuropsychiatry, Toho University Faculty of Medicine, 2. Department of Psychiatry and Implementation Science, Toho University Faculty of Medicine, 3. Sumitomo Pharma Co., Ltd.)

*Kazushige Watabe¹ (1. Tamiya hospital)

*Wataru Omori^1,2, Naoto Kajitani^2,3, Mami Okada-Tsuchioka², Shuken Boku³, Minoru Takebayashi^2,3 (1. Department of Psychiatry, Hiroshima University Hospital, 2. Division of Psychiatry and Neuroscience, Institute for Clinical Research, National Hospital Organization (NHO) Kure Medical Center and Chugoku Cancer Center, 3. Department of Neuropsychiatry, Faculty of Life Science, Kumamoto University)

Yoshiteru Takekita¹, *Yuji Matsumoto², Takahiro Masuda², Kazumasa Yoshida³, Yosuke Koshikawa¹, Masaki Kato¹ (1. Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 2. Medical Science, Sumitomo Pharma Co., Ltd., 3. Data Science, Sumitomo Pharma Co., Ltd.)

*Yoshikazu Morishita¹, Yuki Takamura^1,2, Kyoka Nishimura², Yuto Yokoi¹, Rentarou Idzutsu¹, Natsuko Hitora-Imamura^2,3, Masabumi Minami², Hiroshi Nomura^1,2 (1. Graduate School of Medical sciences, Nagoya City University, 2. Graduate School of Pharmaceutical Sciences, Hokkaido University, 3. Graduate School of Pharmaceutical Sciences, Kumamoto University)

*Shuhei Ueda^1,2, Masahito Hosokawa^3,4,5, Manami Kakita¹, Koji Arikawa⁴, Hiroko Matsunaga⁴, Haruko Takeyama^3,4,5, Sayaka Takemoto-Kimura^1,2 (1. Department of Neuroscience I, Research Institute of Environmental Medicine, Nagoya University, 2. Molecular/Cellular Neuroscience, Nagoya University Graduate School of Medicine, Nagoya University, 3. Department of Life Science and Medical Bioscience, Waseda University, 4. Research Organization for Nano and Life Innovation, Waseda University, 5. Institute for Advanced Research of Biosystem Dynamics, Waseda Research Institute for Science and Engineering)

*Emi Nakamura-Maruyama¹, Naoyuki Himi¹, Takehiro Nakamura¹ (1. Department of Physiology2, Kawasaki Medical School)

*KO MIYOSHI^1,2, Yuanyuan Qin¹, Yuuki Fujiwara¹, Takeshi Yoshimura¹, Taiichi Katayama¹ (1. Dept. of Child Develop. and Molecular Bra. Sci., United Grad. Sch. of Child Develop., Osaka Univ., 2. Molecular Res. Center for Child Mental Develop., United Grad. Sch. of Child Develop., Osaka Univ.)

*Arata Oh-Nishi^1,2,3, Myo-Min Khant¹, Michiyo Fukushima³, Masatoshi Inagaki¹ (1. Department of Psychiatry, Faculty of Medicine, Shimane University, 2. Dapartment of Anatomy, Faculty of Medicine, Kanazawa Medical University, 3. RESVO inc.)

*Jun Nomura¹, Toru Takumi^1,2 (1. Grad Sch Med, Kobe University, 2. RIKEN BDR)

*kunihiko Oishi¹, Keigo Sano¹, Motoki Matsuda¹ (1. Japan Tobacco Inc.)

*Yuhei Suzuki¹, Shuzo Hoshino², Koichi Osonoe², Keiko Nozaki¹, Kenya Watanabe³, Sho Horikoshi⁴, Mizue Ichinose¹, Shoichiro Hirata¹, Yuri Kobayashi¹, Itaru Miura¹ (1. Fukushima Medical University Department of Neuropsychiatry, 2. Takeda General Hospital Department of Psychiatry, 3. Fukushima Medical University Department of Pharmacy, 4. Horikoshi Mental Clinic )

*Junya Matsumoto¹, Harumasa Takano¹, Kiyotaka Nemoto¹, Masaki Fukunaga¹, Kenichiro Miura¹, Tomomi Sugisaki¹, Satsuki Ito¹, Naohiro Okada¹, Shinsuke Koike¹, Go Okada¹, Michihiko Koeda¹, Naoki Hashimoto¹, Kazutaka Ohi¹, Tsutomu Takahashi¹, Jun Miyata¹, Motoaki Nakamura¹, Shinichiro Nakajima¹, Shusuke Numata¹, Manabu Makinodan¹, Naomi Hasegawa¹, Yuka Yasuda¹, Michiko Fujimoto¹, Hidenaga Yamamori¹, Toshiaki Onitsuka¹, Yoshiyuki Watanabe¹, Reiji Yoshimura¹, Shin Nakagawa¹, Norio Ozaki¹, Ryota Hashimoto¹ (1. National Center of Neurology and Psychiatry)

*Kumiko Noda¹, Kazuhide Baba¹, Hiroyuki Fujimura¹, Shiro Yokohama² (1. Department of Pharmacy, Asahikawa medical center, NHO, 2. Department of Clinical Research, Asahikawa medical center, NHO)

*Yutaro Shimamoto^1,2,3, Yoshiki Yasukochi², Yuji Murase¹, Yosuke Koshikawa¹, Toshiya Funatsuki¹, Haruhiko Ogata¹, Reiji Yoshimura⁵, Takeo Saito⁴, Nakao Iwata⁴, Yoshiteru Takekita¹, Toshihiko Kinoshita¹, Kouichiro Higasa², Masaki Kato¹ (1. Department of Neuropsychiatry, Kansai Medical University, 2. Department of Genome Analysis, Institute of Biomedical science, Kansai Medical University, 3. Setagawa Hospital, 4. Department of Psychiatry, Fujita Health University, 5. Department of Psychiatry, University of Occupational and Environmental Health, Japan)

*YUJI MURASE¹, Haruhiko Ogata¹, Yutaro Shimamoto¹, Toshiya Funatsuki¹, Minami Naito¹, Yosuke Koshikawa¹, Hiroki Bando², Yoshiteru Takekita¹, Toshihiko Kinoshita¹, Kenji Hashimoto³, Masaki Kato¹ (1. Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University, 2. Social Welfare Corporation Seishokai Sephiroth Hospital, 3. Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health)

*Soji Tsuboi¹, Kiyoshi Fujita¹ (1. Okehazama Hospital Fujita Kokoro Care Center)

*Takao Kato^1,2, Motohiro Ozone¹, Yuki Hyoudou¹, Minoru Takii¹, Satoshi Mizuki¹, Hiroyuki Mori¹, Kenjirou Wasano¹, Hiroshi Hiejima¹, Mitunari Habukawa¹, Naohisa Uchimura¹ (1. Department of Neuropsychiatry, Kurume University School of Medicine, 2. Department of Psychiatry, Kato Hospital)

*Nakagawa Eiji¹ (1. Department of Epileptology, National Center Hospital, NCNP)

*Toshiya Funatsuki¹, Yosuke Koshikawa¹, Haruhiko Ogata¹, Yuji Murase¹, Yutaro Shimamoto¹, Yoshiteru Takekita¹, Masaki Kato¹ (1. Department of Neuropsychiatry, Faculty of Medicine, Kansai Medical University)

*Hitoshi Sakurai¹, Ken Inada², Yumi Aoki³, Masahiro Takeshima⁴, Kenya Ie⁵, Morito Kise⁶, Eriko Yoshida⁷, Takashi Tsuboi¹, Hisashi Yamada⁸, Hikaru Hori⁹, Yasushi Inada¹⁰, Eiji Shimizu¹¹, Kazuo Mishima⁴, Koichiro Watanabe¹, Yoshikazu Takaesu¹² (1. Department of Neuropsychiatry, Kyorin University Faculty of Medicine, 2. Department of Psychiatry, Kitasato University, School of Medicine, 3. Psychiatric and Mental Health Nursing, St. Luke’s International University, 4. Department of Neuropsychiatry, Akita University Graduate School of Medicine, 5. Department of Internal Medicine, Kawasaki Municipal Tama Hospital, St. Marianna University School of Medicine, 6. Kuji Clinic, Kawasaki Kyodo Hospital, Kawasaki Health Cooperative Association, 7. Department of General Internal Medicine, Kawasaki Kyodo Hospital, Kawasaki Health Cooperative Association, 8. Department of Neuropsychiatry, Hyogo Medicial University, 9. Department of Psychiatry, Faculty of Medicine, Fukuoka University, 10. Medical corporation YUJIN-KAI Inada Clinic, 11. Department of Cognitive Behavioral Physiology, Graduate School of Medicine, Chiba University, 12. Department of Neuropsychiatry, Graduate School of Medicine, University of the Ryukyus)

*Naoki Hashimoto¹, Norio Furukori², Naomi Hasegawa⁹, Hikaru Hori⁴, Hitoshi Iida⁴, Kayo Ichihashi⁵, Shusuke Numata³, Fumitoshi Kodaka⁸, Ryuji Furihata⁷, Ken Inada⁶, Ryota Hashimoto⁹ (1. Department of Psychiatry, Hokkaido University Graduate School of Medicine, 2. Department of Psychiatry, Dokkyo Medical University School of Medicine, Tochigi, Japan, 3. Department of Psychiatry, Institute of Biomedical Science, Tokushima University Graduate School, Tokushima, Japan., 4. Department of Psychiatry, Faculty of Medicine, Fukuoka University, Fukuoka, Japan., 5. Department of Neuropsychiatry, University of Tokyo Hospital, Tokyo, Japan., 6. Department of Psychiatry, Kitasato University School of Medicine, 7. Agency for Student Support and Disability Resources, Kyoto University, 8. Department of Psychiatry, The Jikei University School of Medicine, 9. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.)

*Tomomi NAKATANI¹, Miyu TSURUOKA³, Yoshikazu FUKUI², Kai SAWADA¹, Takashi HORI¹ (1. Graduate school of Humanities, Konan Univ., 2. Konan Univ., 3. DOS Co., Ltd.)

*Hirokazu Yamagishi¹, Yoshihiro Usuda², Yuichiro Watanabe² (1. Department of Pharmacy, Uonuma Kikan Hospital, 2. Department of Psychiatry, Uonuma Kikan Hospital)

*Shunya Aoki¹, Katsutoshi Takada¹, Tatsuru Sugama¹, Mitsugi Kimiwada¹, Tatsuya Hoshino², Takaoki Kaneko³, Shintaro Obata³, Yasuhiro Ota⁴, Satoshi Toishi⁴, Kaori Koike⁵, Hirokazu Akada⁵, Takahisa Saiga⁵, Shigeki Sato⁵ (1. Pharmaceutical Department, Japanese Red Cross Narita Hospital, 2. Nursing Department, Japanese Red Cross Narita Hospital, 3. Department of Obstetrics and Gynecology, Japanese Red Cross Narita Hospital, 4. Department of Neonatology, Japanese Red Cross Narita Hospital, 5. Department of Psychiatry, Japanese Red Cross Narita Hospital)

*Hirotaka Sekiguchi¹ (1. Okehazama Hospital Fujita Mental Care Centre)

*Hideaki Satou¹, Yasuhisa Abe¹, Kenichiro Uchiyama¹, Ryuta Fukunaga¹, Miyamoto Kenshiro¹ (1. Yatsushiro Kousei Hospital)

*Naohisa Tsujino¹, Fuyuka Shimura¹, Shotaro Yamakawa¹, Yoko Toda² (1. Department of Psychiatry, Saiseikai Yokohamashi Tobu Hospital, 2. Department of Palliative Care, Saiseikai Yokohamashi Tobu Hospital)

*Toshimi Owashi¹ (1. MAKITA General Hospital)

Kazuki Fujii^1,2,3, Koshidaka Yumie², Mayumi Adachi², Yuko Yanagibashi², Mina matsuo², Shoko Hongo², Hirofumi Nishizono⁴, Ichiro Takasaki⁵, Nobuyuki Kurosawa^5,7, Yasunori Aizawa⁶, *Keizo Takao^1,2,3,7 (1. Department of Behavioral Physiology, Faculty of Medicine, University of Toyama, 2. Life Science Research Center, University of Toyama, 3. Research Center for Idling Brain Science, University of Toyama, 4. Kanazawa Medical University Medical Research Institute, 5. Faculty of Engineering, University of Toyama, 6. School of Life Science and Technology, Tokyo Institute of Technology, 7. Center for Advanced Antibody Drug Development, University of Toyama,)

*Takahiro Seki^1,2, Tomoko Ohta², Yuri Morikawa², Ayumu Konno³, Hirokazu Hirai³, Yuki Kurauchi², Hiroshi Katsuki² (1. Dept Pharmacol, Fac Pharm Sci, Himeji Dokkyo Univ, 2. Dept Chemico-Pharmacol Sci, Grad Sch Pharm Sci, Kumamoto Univ, 3. Dept Neurophysiol Neural Rep, Gunma Univ Grad Sch Med)

*Kurumi Goto¹, Miku Hirata¹, Mei Onishi¹, Kensuke Yamashita¹, Minoru Narita^1,2, Tomohisa Mori¹ (1. Dept. Pharmacol., Hoshi Univ., Tokyo, Japan, 2. Div. Pathophysiol., Natl. Cancer Ctr. Res. Inst., Tokyo, Japan)

*Takashi Iwai¹, Hayato Ohsumi¹, Momoka Koyama¹, Moka Yoshida¹, Ayano Nagase¹, Misa Oyama¹, Shun Watanabe¹, Mitsuo Tanabe¹ (1. Laboratory of Pharmacology, school of Pharmacy, Kitasato university)

*Masahiro Ohsawa¹, Kousuke Tatsuta⁴, Austin Ganaway³, Ryoma Okada², Yoshinori Sunaga², Yasumi Ohta², Yasemin Akay³, Metin Akay³, Jun Ohta² (1. Faculty of Pharma-Sciences, Teikyo University, 2. Nara Institute of Science and Technology, 3. Cullen College of Engineering, University of Houston, 4. Faculty of Pharmaceutical Sciences, Nagoya City University)

*Zhiqian Yu¹, Mai Sakai², Yoshie Kikuchi¹, Chiaki Ono¹, Mizuki Hino³, Yasuto Kunii³, Hiroaki Tomita¹ (1. Department of Psychiatry, Graduate School of Medicine, Tohoku University, 2. Department of Psychiatric Nursing, Graduate School of Health Science, Tohoku University, 3. Department of Disaster Psychiatry, International Research Institute of Disaster Science (IRIDeS), Tohoku University)

*Megumi Furukawa^1,2, Takayuki Kobayashi³, Ryoken Aoki², Takayuki Manabe⁴, Hideo Matsuzaki¹, Nobuo Izumo³ (1. Dept of Functional Brain Activities, United Grad Sch of Child Dev, 2. Center for Pharmaceutical Education, Yokohama Univ of Pharmacy, 3. Lab of Pharmacotherapy, Yokohama Univ of Pharmacy, 4. Chukyogakuin Univ)

*Naomi Hasegawa¹, Hisashi Yamada², Hikaru Hori³, Norio Yasui-Furukori⁴, Junya Matsumoto¹, Kenichiro Miura¹, Ken Inada⁵, Koichiro Watanabe⁶, Ryota Hashimoto¹ (1. Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, 2. 4.Department of Neuropsychiatry, Hyogo Medical University, Hyogo, 3. 5.Department of Psychiatry, Faculty of Medicine, Fukuoka University, 4. 3.Department of Psychiatry, Dokkyo Medical University School of Medicine, 5. 9.Department of Psychiatry, Kitasato University, School of Medicine, 6. 17.Department of Neuropsychiatry, Kyorin University School of Medicine)

*Masahiro Takeshima¹, Akise Umakoshi¹, Yoshizawa Kazuhisa¹, Masaya Ogasawara¹, Yu Itoh¹, Kazuo Mishima¹ (1. Department of Neuropsychiatry, Akita University Graduate School of Medicine)

*Minoru Urata¹, Fumihiko Ueno², Takahito Uchida^3,4, Yasuyuki Matsumoto¹, Masami Murao¹, Taku Maruki¹, Masayuki Tomita⁵, Takashi Tsuboi¹, Koichiro Watanabe¹, Hitoshi Sakurai¹ (1. Department of Neuropsychiatry, Kyorin University Faculty of Medicine, 2. Brain Health Imaging Centre, Centre for Addiction and Mental Health, 3. Uchida clinic, 4. Department of Neuropsychiatry, Keio University School of Medicine, 5. Oizumi hospital)

*Masahide Karashima¹, hitomi ueki¹, kazuhiro onuma¹, makoto hiraide², takahiro terunuma¹, takahumi hori³ (1. Ibaraki Prefectural Medical Center of Psychiatry,Pharmacy Division, 2. School of Pharmacy and Pharmaceutical Sciences,Hoshi University, 3. Ibaraki Prefectural Medical Center of Psychiatry)

*Chika Nakayama¹, Yukina Miyagi^2,3, Saori Gocho^2,3,4, Yuka Miyachi², Taeyuki Oshima² (1. Faculty of Pharmacy, Gifu University of Medical Science, 2. College of Pharmacy, Kinjo Gakuin University, 3. Graduate School of Medicine, Aichi Medical University, 4. Department of Pharmacy, Nagoya Ekisaikai Hospital)

*Yosuke Koshikawa¹, Chikashi Takano^1,2, Toshiya Funatsuki¹, Yuji Murase¹, Hiroki Bando³, Minami Minami¹, Haruhiko Ogata¹, Yutaro Shimamoto⁴, Atsuko Yamamoto¹, Shoko Takano¹, Toshihiko Kinoshita¹, Masaki Kato¹, Yoshiteru Takekita¹ (1. Department of Neuropsychiatry. Kansai Medical University, 2. Kobe Shirasagi Hospital Group, 3. Sephiroth Hospital, 4. Setagawa Hospital)

*Hirotaka Tominaga¹, Taro Suwa², Toshiyuki Shimizu³, Nobuatsu Aoki^3,4,5, Kazuyuki Yasuda⁶, Niina Utinuma⁶, Aran Tajika⁷, Yoshiteru Takekita³ (1. Showakai Mojimatsugae Hospital, 2. Department of Psychiatry, Graduate School of Medicine, Kyoto University, 3. Department of Neuropsychiatry, Kansai Medical University, 4. Psychiatry and Mental Health, University of New South Wales, 5. Black Dog Institute, Sydney, 6. Department of Neuropsychiatry, University of Yamanashi Faculty of Medicine., 7. Health Promotion and Human Behavior, Kyoto University Graduate School of Medicine / School of Public Health)

*Kaori Hojo¹, Hiromiti Yamanishi², Christopher J Kline³ (1. Harima Sanatorium, 2. Hirakata Ryoiku Social welfare corporation, 3. Mayo Clinic)

*Yuki Kageyama¹, Yasuhiko Deguchi¹, Shohei Okura¹, Koki Inoue¹, Conor Liston² (1. Graduate School of Medicine, Osaka Metropolitan University, 2. Department of Psychiatry and Feil Family Brain and Mind Research Institute, Weill Cornell Medicine)

*Masahiro Ohgidani¹, Kato TA Takahiro², Tanaka Yusuke¹, Furube Eriko¹, Yoshida Shigetaka¹ (1. Department of Functional Anatomy and Neuroscience, Asahikawa Medical University, 2. Department of Neuropsychiatry Graduate School of Medical Sciences Kyushu University")

*Kazhiro Hada¹, Yoshiaki Ohi², Yuki Murata³, Kayoko Ozeki¹, Yoshifumi Wakiya¹ (1. Laboratory of Pharmacy Practice and Sciences, Aichi Gakuin University, 2. Laboratory of Neuropharmacology, School of Pharmacy, Aichi Gakuin University, 3. Laboratory of Organic and Medicinal Chemistry, School of Pharmacy, Aichi Gakuin University )

*Kenya Watanabe¹, shingen Misaka², Keiko Kanno-Nozaki³, Sae Endo¹, Yuhei Suzuki³, Yuri Koboyashi³, Shoichiro Hirata³, Mizue Ichinose³, Sho Horikoshi⁴, Takahiro Suto¹, Junko Kuroda¹, itaru Miura³ (1. Department of Pharmacy, Fukushima Medical University Hospital, 2. Department of Bioregulation and Pharmacological Medicine, School of Medicine, Fukushima Medical University School of Medicine, 3. Department of Neuropsychiatry, School of Medicine, Fukushima Medical University School of Medicine, 4. HORIKOSHI psychosomatic clinic)

*Toshiharu Kamishikiryo¹, Eri Itai¹, Yuki Mitsuyama¹, Miyuki Kato¹, Go Okada¹ (1. Department of Psychiatry and Neurosciences. Graduate School of Biomedical & Health Sciences, Hiroshima University.)

*Hiroaki Mori^1,2, Shinichiro Ochi¹, Hidetoshi Hashida², Jun-Ichi Iga¹, Shu-Ichi Ueno¹ (1. Department of Neuropsychiatry, Molecules and Function, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime, 791-0295, Japan., 2. Department of Neuropsychiatry, Shokokai Imabari Hospital, Takaichi 786-13, Imabari, Ehime, Japan.)

*Shusaku Fukutake¹, Yuka Takai¹, Eri Nakaoka¹, Soichiro Sato¹, Mitsuru Hikiji¹ (1. Social Medical Corporaition Takami Tokufuukai Kibougaoka Hospital)

Jun Takahashi¹, Kota Kikuchi¹, Yasushi Kawamata¹, *Norio Furukori¹ (1. Department of Psychiatry, Dokkyo Medical University School of Medicine)

*Keiichirou Nakae¹, Nahoko Watanabe¹, Chiaki Hashimoto¹, Taisei Yamashita¹, Minoru Urata¹, Mayo Kotani¹, Yuki Aoshika², Hitoshi Sakurai¹, Takashi Tsuboi¹, koichiro Watanabe¹ (1. Kyorin University Faculty of Medicine Psychiatry and neurology, 2. Kyorin University Faculty of Medicine Nursing Department)

*Chiharu Tamagaki¹, Toshihiko Kinoshita¹ (1. Kansai Medical University)

*Chiharu Tamagaki¹, Toshihiko Kinoshita¹ (1. Kansai Medical University)